REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 122 filers reported holding REATA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $714,434 | +70.6% | 7,007 | +52.1% | 0.04% | +46.2% |
| Q1 2023 | $418,778 | +64.2% | 4,606 | +81.9% | 0.03% | +188.9% |
| Q3 2021 | $255,000 | -34.8% | 2,532 | -8.4% | 0.01% | -30.8% |
| Q2 2021 | $391,000 | +73.0% | 2,763 | +51.4% | 0.01% | +30.0% |
| Q4 2020 | $226,000 | -26.1% | 1,825 | -6.9% | 0.01% | -41.2% |
| Q2 2020 | $306,000 | +1.7% | 1,960 | -6.1% | 0.02% | -26.1% |
| Q1 2020 | $301,000 | -36.2% | 2,087 | -9.6% | 0.02% | +9.5% |
| Q4 2019 | $472,000 | +60.5% | 2,308 | -35.7% | 0.02% | +90.9% |
| Q3 2018 | $294,000 | – | 3,590 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $76,391,000 | 14.09% |
| Opaleye Management Inc. | 330,000 | $8,702,000 | 1.85% |
| Highlander Partners, L.P. | 27,600 | $728,000 | 0.89% |
| Ikarian Capital, LLC | 200,000 | $5,274,000 | 0.79% |
| Integral Health Asset Management, LLC | 103,000 | $2,716,000 | 0.75% |
| KRS Capital Management, LLC | 32,841 | $866,000 | 0.74% |
| Ghost Tree Capital, LLC | 55,000 | $1,450,000 | 0.52% |
| MADDEN SECURITIES Corp | 39,312 | $1,037,000 | 0.49% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $801,000 | 0.47% |
| Ikarian Capital, LLC | 100,000 | $2,637,000 | 0.39% |